Schaefer Thomas J.'s Form 4 filing
Arcadia Biosciences, Inc. (RKDA) · filed Aug 7, 2023
- Accession no.
- 0001209191-23-044889
- Filed
- Aug 7, 2023
- Trade date
- Aug 4, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.38K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schaefer Thomas J.CIK 0001960808 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | Common Stock | PPurchaseAcquired | +649 | $3.67 | +$2,381.83 | 719 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.